TRIAMINIC COUGH & SORE THROAT OTC
Generic Name and Formulations:
Acetaminophen 160mg, dextromethorphan HBr 5mg; per 5mL; liq; grape flavor; alcohol-free; contains sodium 5mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC COUGH & SORE THROAT:
Cough, fever, sore throat, headache, minor aches and pains.
<4yrs: do not use. 4–6yrs: 5mL. 6–12yrs: 10mL. Repeat every 4 hours as needed; max 5 doses/24 hours.
Children <4yrs old. During or within 14 days of MAOIs. Concomitant other acetaminophen products.
Asthma. Lower respiratory disorders. Liver disease. Discontinue if symptoms worsen or persist for ≥3 days.
See Contraindications. Hypertensive crisis with MAOIs.
Antitussive + analgesic/antipyretic.
Endocrinology Advisor Articles
- Predictors of Success for Insulin-to-Liraglutide Switch for Type 2 Diabetes
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Pre-Pregnancy Programs May Improve Outcomes in Women With Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- IV Fluid Infusion Rates Do Not Affect Pediatric DKA Neurologic Outcomes
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk